Чтение онлайн

216. Silverstone T. Appetite suppressants. /Drugs. 1992 43. 6. 820-836

217. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998 Jul 18;352(9123):167-72

218. Skov AR, Toubro S, Ronn B, Holm L, Astrup A Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord 1999 May;23(5):528-36

219. Soundararajan V; Hart NB; Royston CM Abdominoplasty following vertical banded gastroplasty for morbid obesity. Br J Plast Surg 1995 Sep;48(6):423-7

220. Stern JS; Hirsch J; Blair SN; Foreyt JP; Frank A; Kumanyika SK; Madans JH; Marlatt GA; St Jeor ST; Stunkard AJ Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res 1995 Nov;3(6):591-604

221. Stern M Epidemiology of obesity and its link to heart disease. Metabolism 1995 Sep;44(9 Suppl 3):1-3

222. Straznicky NE, O'Callaghan CJ, Barrington VE, Louis WJ Hypotensive effect of low-fat, high-carbohydrate diet can Be independent of changes in plasma insulin concentrations. Hypertension 1999 Oct;34(4 Pt 1):580-5

223. Sugerman HJ; Felton WL 3rd; Salvant JB Jr; Sismanis A; Kellum JM Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995 Sep;45(9):1655-9

224. Trappe S. W. Aging among elite distance runners: a 22-yr longitudinal study / D. L. Costill, M. D. Vukovich, J. Jones, T. Melham // J. Appl. Physiol.
– 1997.
– Vol. 80, ( 1.
– P. 285-290.

225. Tremblay A. Human obesity: a defect of lipid oxidation or in thermogenesis? Int. J. Obes. 1992.
– V.16.
– P. 953-957.

226. Tremblay A., Fontaine E., Poehlman E. T. et al., The effect of exercise-training on resting metabolic rate in lean and moderately obese individuals. Int. J. Obes. 1986 10 511-517.

227. Valtuena S; Blanch S; Barenys M; Sola R; Salas-Salvado J Changes in body composition and resting energy expenditure after rapid weight loss: is there an energy-metabolism adaptation in obese patients? Int J Obes Relat Metab Disord 1995 Feb;19(2):119-25

228. van Baak MA Exercise training and substrate utilisation in obesity. Int J Obes Relat Metab Disord 1999 Apr;23 Suppl 3:S11-7

229. Vander Tuig JG, Beneke WM Low-protein diet blocks development of hyperphagia and obesity in rats with hypothalamic knife cuts. J Nutr 1996 Jun;126(6):1713-21

230. Vara L., Agras S Caloric intake and activity levels are related in yong children Int. J. Obes. 1989 13 613-617.

231. Viru A., Smirnova T. Health promotion and exercise training // Sports Med.
– 1995.
– Vol. 19.
– P. 123-136.

232. Wannamathee G., Shaper A. G. Weight change in middle-aged British men: implications for health. Eur. J. Clin. Nutr. 1989 44 133-142

233. Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment. J Am Coll Cardiol 1999 Dec;34(7):2088-95

234. Wells JC Is obesity really due to high energy intake or low energy expenditure? Int J Obes Relat Metab Disord 1998 Nov;22(11):1139-40

235. Weyer C, Snitker S, Rising R, Bogardus C, Ravussin E Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord 1999 Jul;23(7):715-22

236. Wilkinson P. W., Parkin J. M., Pearlson G. et al., Energy intake and physical activity in obese children. Br. Med. J. 1977, i 756

237. Willett WC Is dietary fat a major determinant of body fat? Am J Clin Nutr 1998;67:556S-562S.

238. Williams KV, Mullen ML, Kelley DE, Wing RR The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 1998 Jan;21(1):2-8

239. Wilmore JH Increasing physical activity: alterations in body mass and composition. Am J Clin Nutr 1996 Mar;63(3 Suppl):456S-460S

240. Wing RR. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995 May;95(5):569-72; quiz 573-4

241. Wolf A. M.; Colditz G. A. Social and economic effects of body weight in the United States. Am. J. Clin. Nutr. 1996.
– V. 63., N3. (Suppl).
– P. 466S-469S

242. Wong J, Reddy SS, Klein AL Anorectic drugs and valvular heart disease: a biological and clinical perspective. Cleve Clin J Med 1998 Jan;65(1):35-41

243. Wurtman J, Wurtman R, Reynolds S et al., D-fenfluramine supresses snack intake among carbohydrate cravers but not among non-carbohydrate cravers. Inter. J. Eat. Disord.- 1987.
– V.6.,N8.
– P. 687-699.

244. Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K; et al., Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 1995 Jun;18(6):775-8

245. Yki-Jarvinen H, Nikkila K, Makimattila S Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs 1999;58 Suppl 1:53-4; discussion 75-82

246. Zhi J., Melia A. T., Guerciolini R., et al., Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol. Ther. 1994 56 82-85].

247. Zhi J; Melia AT; Eggers H; Joly R; Patel IH Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. J Clin Pharmacol 1995 Nov;35(11):1103-8].

248. Zimmet P, Collier G Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg. Drugs 1999;58 Suppl 1:21-8; discussion 75-82